Abstract
Mitochondria are attractive organelles that have the potential to contribute greatly to medical therapy. This organnelle is responsible for a variety of essential functions including ATP production and the regulation of apoptosis, and they have their own genome, mitochondrial DNA (mtDNA). It has recently become evident that a variety of human diseases are associated with mitochondrial dysfunctions caused by mutations and defects in mtDNA. Therefore, the ability to successfully target the mitochondrial genome and to regulate mitochondrial gene expression would contribute to mitochondrial gene therapy for various human diseases. To achieve such an innovative objective, it will be necessary to deliver various cargoes to mitochondria in living cells. However, only a limited number of approaches are available for accomplishing this. In this chapter, we discuss problems associated with mitochondrial delivery systems and mitochondrial gene expression, and propose a strategy for overcoming these problems based our current efforts. To this end, we highlight a MITO-Porter, a mitochondrial delivery system, and show some examples of the regulation of mitochondrial gene expression including mitochondrial RNA knockdown and mitochondrial transgene expression.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Biswas S, Torchilin VP (2014) Nanopreparations for organelle-specific delivery in cancer. Adv Drug Deliv Rev 66:26–41. https://doi.org/10.1016/j.addr.2013.11.004
Cardoso AM, Morais CM, Cruz AR, Cardoso AL, Silva SG, do Vale ML, Marques EF, Pedroso de Lima MC, Jurado AS (2015) Gemini surfactants mediate efficient mitochondrial gene delivery and expression. Mol Pharm 12(3):716–730. https://doi.org/10.1021/mp5005349
D’Souza GG, Rammohan R, Cheng SM, Torchilin VP, Weissig V (2003) DQAsome-mediated delivery of plasmid DNA toward mitochondria in living cells. J Control Release 92(1–2):189–197
Endo T, Nakayama Y, Nakai M (1995) Avidin fusion protein as a tool to generate a stable translocation intermediate spanning the mitochondrial membranes. J Biochem (Tokyo) 118(4):753–759
Flierl A, Jackson C, Cottrell B, Murdock D, Seibel P, Wallace DC (2003) Targeted delivery of DNA to the mitochondrial compartment via import sequence-conjugated peptide nucleic acid. Mol Ther 7(4):550–557
Furukawa R, Yamada Y, Kawamura E, Harashima H (2015) Mitochondrial delivery of antisense RNA by MITO-porter results in mitochondrial RNA knockdown, and has a functional impact on mitochondria. Biomaterials 57:107–115. https://doi.org/10.1016/j.biomaterials.2015.04.022
Lyrawati D, Trounson A, Cram D (2011) Expression of GFP in the mitochondrial compartment using DQAsome-mediated delivery of an artificial mini-mitochondrial genome. Pharm Res 28(11):2848–2862. https://doi.org/10.1007/s11095-011-0544-0
Sato Y, Sakurai Y, Kajimoto K, Nakamura T, Yamada Y, Akita H, Harashima H (2017) Innovative technologies in nanomedicines: from passive targeting to active targeting/from controlled pharmacokinetics to controlled intracellular pharmacokinetics. Macromol Biosci 17(1). https://doi.org/10.1002/mabi.201600179
Suda T, Liu D (2007) Hydrodynamic gene delivery: its principles and applications. Mol Ther 15(12):2063–2069. https://doi.org/10.1038/sj.mt.6300314
Yamada Y, Harashima H (2014) A method for screening mitochondrial fusogenic envelopes for use in mitochondrial drug delivery. Methods Mol Biol 1141:57–66. https://doi.org/10.1007/978-1-4939-0363-4_2
Yamada Y, Akita H, Kamiya H, Kogure K, Yamamoto T, Shinohara Y, Yamashita K, Kobayashi H, Kikuchi H, Harashima H (2008) MITO-porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusion. Biochim Biophys Acta 1778(2):423–432. https://doi.org/10.1016/j.bbamem.2007.11.002
Yasuzaki Y, Yamada Y, Kanefuji T, Harashima H (2013) Localization of exogenous DNA to mitochondria in skeletal muscle following hydrodynamic limb vein injection. J Control Release 172(3):805–811. https://doi.org/10.1016/j.jconrel.2013.09.029
Yasuzaki Y, Yamada Y, Ishikawa T, Harashima H (2015) Validation of mitochondrial gene delivery in liver and skeletal muscle via hydrodynamic injection using an artificial mitochondrial reporter DNA vector. Mol Pharm 12(12):4311–4320. https://doi.org/10.1021/acs.molpharmaceut.5b00511
Yu H, Koilkonda RD, Chou TH, Porciatti V, Ozdemir SS, Chiodo V, Boye SL, Boye SE, Hauswirth WW, Lewin AS, Guy J (2012) Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse model. Proc Natl Acad Sci U S A 109(20):E1238–E1247. https://doi.org/10.1073/pnas.1119577109
Zhang E, Zhang C, Su Y, Cheng T, Shi C (2011) Newly developed strategies for multifunctional mitochondria-targeted agents in cancer therapy. Drug Discov Today 16(3–4):140–146. https://doi.org/10.1016/j.drudis.2010.12.006. S1359-6446(10)00844-5 [pii]
Acknowledgements
This work was supported, in part, by the Scientific Research (B) from the Ministry of Education, Culture, Sports, Science and Technology of Japanese Government (MEXT). We also thank Dr. Milton Feather for his helpful advice in writing the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Yamada, Y., Harashima, H. (2018). Targeting the Mitochondrial Genome Through a Nanocarrier and the Regulation of Mitochondrial Gene Expression. In: Oliveira, P. (eds) Mitochondrial Biology and Experimental Therapeutics. Springer, Cham. https://doi.org/10.1007/978-3-319-73344-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-319-73344-9_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-73343-2
Online ISBN: 978-3-319-73344-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)